Thrombin induces expression of twist and cell motility via the hypoxia-inducible factor-1α translational pathway in colorectal cancer cells

✍ Scribed by Li-Hsun Chang; Chun-Han Chen; Der-Yi Huang; Hui-Chen Pai; Shiow-Lin Pan; Che-Ming Teng

• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 407 KB
• Volume: 226
• Category: Article
• ISSN: 0021-9541
• DOI: 10.1002/jcp.22428

✦ Synopsis

Abstract

Deep vein thrombosis associated with advanced cancer is known as Trousseau's syndrome. We hypothesized that thrombin, an activator of protease‐activated receptor (PAR)‐1 and PAR‐4 contributes to tumor metastasis. In this study, we demonstrated that thrombin and the PAR‐1 activating peptide (AP) SFLLRN, but not the PAR‐4 AP GYPGKF, induced HIF‐1α activities, protein expression, and cell motility in colorectal cancer cells, and these actions were significantly inhibited by the PAR‐1 antagonist SCH79797. Moreover, thrombin‐induced HIF‐1α activity and cell motility were blocked by inhibiting important mediators of signaling transduction, including the ERK, PI3K, and mTOR pathways. These results showed that thrombin induced HIF‐1α protein expression through PAR‐1 and HIF‐1α translational de novo protein synthesis. Twist can regulate epithelial–mesenchymal transition (EMT) and increase tumor metastasis. However, we observed that thrombin‐induced HIF‐1α increased Twist mRNA and its protein level was mediated by the modulation of PAR‐1 activation and the HIF‐1α translational pathway. In addition, Twist could increase N‐cadherin but not E‐cadherin to promote tumor metastasis. Overexpression of dominant‐negative HIF‐1α reversed thrombin‐mediated Twist and Twist‐induced N‐cadherin expression. Moreover, siTwist inhibited Twist‐induced N‐cadherin and Thrombin‐induced cell motility. In conclusion, our study showed that thrombin‐induced HIF‐1α upregulated Twist at the transcriptional level to enhance cell motility. These findings show that thrombin upregulates Twist via HIF‐1α to make tumor cells malignant and also establish a link between the coagulation disorder and cancer metastasis. J. Cell. Physiol. 226: 1060–1068, 2011. © 2010 Wiley‐Liss, Inc.